We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should You Dump Monsanto (MON) Stock from Your Portfolio?
Read MoreHide Full Article
On Aug 16, 2016, we issued an updated research report on premium agro-chemical firm Monsanto Company . The company, along with its subsidiaries, is one of the leading providers of agricultural products globally.
Bearish Factors
Commercial rivalry in the global seeds, traits and agricultural chemical industry is significantly increasing. Stiff competition exposes Monsanto to risks of market share loss. This is because the successful launch of a new product by any rival can substantially lower the market value of the existing products offered by the company.
In order to stay ahead of the competition and lower the bargaining power of prospective end users, Monsanto heavily invests in research & development to fortify its existing product portfolio. However, such investments add to the existing debt burden of the company and older technology often become obsolete within a limited time span. Moreover, international operations of the company are subjected to several economic, political and environmental headwinds.
Also, Monsanto’s cost and sales are highly sensitive to commodity price fluctuations. Economic slowdown in major emerging markets such as China have lowered demand for agricultural products and hence, weighed on the company’s market prices in recent times. Weak agro products prices are also weighing over Monsanto’s revenues and margins. Given that incomes of farmers are directly related to agro-product prices, lower prices are reducing farmers’ income and adversely affecting their seed and chemical product purchasing decisions, thereby hurting Monsanto’s top line and bottom line.
Scope for Growth
The Zacks Rank #4 (Sell) stock has undertaken certain initiatives that alongside the favorable market conditions might partially offset the impact of the negatives. For instance, rise in global population, increase in the proportion of middle-income group consumers and improving individual dietary habits are expected to enhance agricultural demand and in turn, sales of farming products offered by Monsanto. Moreover, the company is trying to improve its liquidity position through cash management and aims to generate free cash in the range of $1.6–$1.8 billion in fiscal 2016.
Stocks to Consider
Some better-ranked stocks in the industry include Barrick Gold Corporation , First Majestic Silver Corp. (AG - Free Report) and Axiall Corporation . All the three companies currently hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should You Dump Monsanto (MON) Stock from Your Portfolio?
On Aug 16, 2016, we issued an updated research report on premium agro-chemical firm Monsanto Company . The company, along with its subsidiaries, is one of the leading providers of agricultural products globally.
Bearish Factors
Commercial rivalry in the global seeds, traits and agricultural chemical industry is significantly increasing. Stiff competition exposes Monsanto to risks of market share loss. This is because the successful launch of a new product by any rival can substantially lower the market value of the existing products offered by the company.
In order to stay ahead of the competition and lower the bargaining power of prospective end users, Monsanto heavily invests in research & development to fortify its existing product portfolio. However, such investments add to the existing debt burden of the company and older technology often become obsolete within a limited time span. Moreover, international operations of the company are subjected to several economic, political and environmental headwinds.
Also, Monsanto’s cost and sales are highly sensitive to commodity price fluctuations. Economic slowdown in major emerging markets such as China have lowered demand for agricultural products and hence, weighed on the company’s market prices in recent times. Weak agro products prices are also weighing over Monsanto’s revenues and margins. Given that incomes of farmers are directly related to agro-product prices, lower prices are reducing farmers’ income and adversely affecting their seed and chemical product purchasing decisions, thereby hurting Monsanto’s top line and bottom line.
Scope for Growth
The Zacks Rank #4 (Sell) stock has undertaken certain initiatives that alongside the favorable market conditions might partially offset the impact of the negatives. For instance, rise in global population, increase in the proportion of middle-income group consumers and improving individual dietary habits are expected to enhance agricultural demand and in turn, sales of farming products offered by Monsanto. Moreover, the company is trying to improve its liquidity position through cash management and aims to generate free cash in the range of $1.6–$1.8 billion in fiscal 2016.
Stocks to Consider
Some better-ranked stocks in the industry include Barrick Gold Corporation , First Majestic Silver Corp. (AG - Free Report) and Axiall Corporation . All the three companies currently hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>